HOME ABOUT US NEWS JOBS LINKS CONTACT
DRUG FAMILY
  MECHANISM 2
  TRI-N 2755
  SCIENTIFIC DATA 1
 
  CLINICAL STATUS
   
   
   
   
Accumulation of TRIN molecules in tumour cells.

Due to their tripartite molecular structure TRIN molecules are able to accumulate in tumour cells. Directly located in the disease area TRIN molecules can develop their cytotoxic function by inhibiting cell proliferation. Their good metabolic compatibility helps to reduce the probability of side effects and adverse events.